The up-regulation of NK-1R expression in AML patients led us to perform an in-depth characterization of NK-1R function in the CML cell line K562 and the AML cell line HL60. The gene discussed is TACR1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.